Olympus launches paracetamol overdose test
This article was originally published in Clinica
Executive Summary
Olympus has launched its Enzymatic Paracetamol test, designed to measure overdose of the drug, in the UK and Ireland. CE marked for sale in Europe, the test uses serum or heparinised plasma and can produce results in under 12 minutes, the Japanese firm told Clinica. It added that because the test was the first Olympus paracetamol product specifically developed for use on company's instrumentation, it has "enhanced calibration stability" over the product previously used on Olympus's equipment, Audit Diagnostics' OAR6905. It also simplifies the process for operators and produces less waste. Other paracetamol assays include Applied Biotech's point-of-care, finger-stick blood test, which was launched in the UK in 2002.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.